XT
NMTC icon

XTX Topco’s NeuroOne Medical Technologies NMTC Stock Holding History

XTX Topco’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,214
Closed -$33.6K – 4528
2026
Q1 		$33.6K Sell
7,214
-7,028
-49% -$33.8K ﹤0.01% 3426
2025
Q4 		$64.8K Buy
14,242
+10,860
+321% +$49.5K ﹤0.01% 2765
2025
Q3 		$18K Sell
3,382
-9,224
-73% -$45.2K ﹤0.01% 2348
2025
Q2 		$51.3K Buy
+12,606
New +$46.5K ﹤0.01% 2010
2025
Q1 		– Sell
-3,087
Closed -$15.3K – 2860
2024
Q4 		$15.3K Sell
3,087
-1,314
-30% -$6.55K ﹤0.01% 2087
2024
Q3 		$26.1K Buy
+4,401
New +$22K ﹤0.01% 1795

Other funds holding NMTC

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

XTX Topco's NMTC Position: Q2 2026 in Review

XTX Topco sold out of NeuroOne Medical Technologies (NMTC) in Q2 2026, closing a stake of 7,214 shares — an estimated $33.6K sold.

XTX Topco first reported a position in NMTC in Q3 2024 and held it in 6 quarters. The position peaked at $64.8K in Q4 2025. 27 funds tracked by Wall St. Rank hold NMTC as of Q2 2026.

  • XTX Topco reported no remaining NeuroOne Medical Technologies position as of Q2 2026 after selling out during the quarter.
  • XTX Topco sold 7,214 NeuroOne Medical Technologies shares in Q2 2026, an estimated $33.6K.
  • XTX Topco first reported a position in NeuroOne Medical Technologies in Q3 2024 and held it in 6 quarters.
  • XTX Topco's NeuroOne Medical Technologies position peaked at $64.8K in Q4 2025.
  • 27 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.